Prevention of preeclampsia: A randomized trial of atenolol in hyperdynamic patients before onset of hypertension

Obstetrics and Gynecology

Volumn 93, Issue 5, 1999, Pages 725-733

  EASTERLING, THOMAS R ^a   BRATENG, DEBRA ^a   SCHMUCKER, BARBARA ^a   BROWN, ZANE ^b   MILLARD, STEVEN P ^b  

^a Obstetrics and Gynecology of Atlanta   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART OUTPUT; HEMODYNAMIC MONITORING; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ATENOLOL; BIRTH WEIGHT; CARDIAC OUTPUT; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; RISK FACTORS;

EID: 0032927315     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00522-5     Document Type: Article

References (24)

1. Gant N, Daley G, Chand S, Whalley P, MacDonald P. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682-9.
2. Gant N, Madden J, Siiteri P, MacDonald P. A sequential study of the metabolism of dehydroisoandrosterone sulfate in primigravid pregnancy. Endocrinology 1972;273:1026-31.
3. Lockwood C, Peters J. Increased plasma levels of EDT cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 1990;162:358-62.
4. CLASP (Collaborative Group). CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994;343:619-29.
5. Levine R, Hauth J, Curet L, Sibai B, Catalano P, Morris C, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997;337:69-76.
6. Sibai B, Caritis S, Thom E, Klebanoff M, McNellis D, Rocco L, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993;329:1213-8.
7. Easterling T, Benedetti T, Schmucker B, Millard S. Maternal hemodynamics in normal and preeclamptic pregnancies: A longitudinal study. Obstet Gynecol 1990;76:1061-9.
8. Easterling T, Benedetti T, Carlson K, Brateng D, Wilson J, Schmucker B. The effect of maternal hemodynamics on fetal growth in hypertensive pregnancies. Am J Obstet Gynecol 1991; 165:902-6.
9. Easterling T, Benedetti T, Schmucker B, Carlson K. Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring. Am J Perinatol 1989;6:86-9.
10. Rubin P, Clark D, Sumner D, Low R, Butters L, Reynolds B, et al. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1983;1:431-4.
11. Butters L, Kennedy S, Rubin P. Atenolol in essential hypertension during pregnancy. BMJ 1990;301:587-9.
12. Collins R, Wallenburg H. Pharmacological prevention and treatment of hypertensive disorders in pregnancy. In: Chalmers I, Enkin M, Keirse M, eds. Effective care in pregnancy and childbirth. New York: Oxford University Press, 1989:512-33.
13. Easterling T, Carlson K, Schmucker B, Brateng D, Benedetti T. Measurement of cardiac output in pregnancy by Doppler technique. Am J Perinatol 1990;7:220-2.
14. Easterling T, Watts D, Schmucker B, Benedetti T. Measurement of cardiac output during pregnancy: Validation of Doppler technique and clinical observations in preeclampsia. Obstet Gynecol 1987;69:845-50.
15. Schwartz L, Gewert B, Bissell M. Chemical assay of ρ-aminohippuric acid simplified by use of dimethylaminocinnamaldehyde in ethanol. Clin Chem 1988;34:165-70.
16. Richterich R. Clinical chemistry theory and practice. New York: Academic Press, 1969:477-8.
17. Hughes G. Obstetric-gynecologic terminology. Philadelphia: FA Davis, 1972:422-3.
18. Babson S, Behrman R, Lessel R. Fetal growth: Liveborn birth weights for gestational age of white middle class infants. Pediatrics 1970;45:937-43.
19. Lindstrom M, Bates D. Algorithms for the linear mixed-effects models for repeated measures data. J Am Stat Assoc 1988;83:1014-22.
20. Feldman H. Families of lines: Random effects in linear regression analysis. J Appl Physiol 1988;64:1721-31.
21. Steyn W, Odendaal H. Randomised controlled trial of ketanserin and asprin in prevention of preeclampsia. Lancet 1997;350:1267-71.
22. Easterling T, Schmucker B, Selke S, Millard S. Maternal weight, hemodynamics, and preeclampsia. Hypertens Preg 1997;16:379-88.
23. Chesley L, Duffus G. Preeclampsia, posture and renal function. Obstet Gynecol 1971;38:1-9.
24. Easterling T, Benedetti T. Preeclampsia: A hyperdynamic disease model. Am J Obstet Gynecol 1989;160:1147-53.